Patterned Electrical Neuromuscular Stimulation and Therapeutic Exercise for Osteoarthritis of the Knee: Pilot Study

NCT00701506 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2011-12-09

No results posted yet for this study

Summary

The purpose of the study is to investigate the benefits of the Patterned Neuromuscular Electrical Stimulation (PENS) for the treatment of osteoarthritis. The rationale for this investigation is to assess the benefit of PENS in the alleviation of symptoms of osteoarthritis and elucidating the mechanism of action of PENS.

Conditions

Interventions

DEVICE

Patterned Electrical Neuromuscular Stimulation

* 20-minute session, to each affected knee, 3 times per week for 12 weeks. * PENS for 20 minutes: * Tri-phasic Lower Extremity stimulation pattern based on activation timing of the quadriceps and hamstrings for strength training (50 Hz impulses for 200 ms every 1500 ms). * Minimal twitch for 5 minutes. * Moderate to strong, but well-tolerated twitch contractions for 15 minutes. * Electrodes placed on quadriceps and hamstrings

DEVICE

Placebo PENS

* 20-minute session, to each affected knee, 3 times per week for 12 weeks. * Placebo PENS for 20 minutes: * Electrodes placed on quadriceps and hamstrings.

Sponsors & Collaborators

  • Accelerated Care Plus

    collaborator INDUSTRY
  • Research Institute of Health and Science (RIHSE)

    collaborator UNKNOWN
  • RS Medical

    lead INDUSTRY

Principal Investigators

  • William Carroll · RS Medical

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-05-31
Primary Completion
2010-10-31
Completion
2010-11-30

Countries

  • Japan

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00701506 on ClinicalTrials.gov